Gelteq Limited Ordinary Shares (GELS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $0.75
• Market Cap: $7.56M
• EPS: $-0.51
• 52-Week High: $4.11
• 52-Week Low: $0.67

About Gelteq Limited Ordinary Shares

Gelteq Limited (GELS) is a pioneering biotechnology company based in Caulfield, Australia, dedicated to the development and commercialization of innovative gel-based drug delivery systems for both human and veterinary medicine. Employing advanced technologies, Gelteq is focused on enhancing the effectiveness and safety of therapeutic treatments, thereby establishing itself as a significant entity within the biopharmaceutical industry. With a strong emphasis on research and development, the co...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Gelteq Limited Ordinary Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GELS pay dividends?

Gelteq Limited Ordinary Shares (GELS) does not currently pay a regular dividend.

What is GELS's market cap?

Gelteq Limited Ordinary Shares (GELS) has a market capitalization of $7.56M with a current stock price of $0.75.